REAL-WORLD DATA IN INFLAMMATORY BOWEL DISEASES ON VEDOLIZUMAB THERAPY: INTERIM ANALYSIS OF THE NON-INTERVENTIONAL LISTEN II STUDY

Hermann Schulze  1     Niels Teich  2     Andreas Stallmach  3     Taner Cavlar  4     Jana Knop  4     Sonja Henneberger  5    
1 Agaplesion Markus-Hospital, Frankfurt am Main, Germany
2 Group Practice in Internal Medicine for Digestive and Metabolic Diseases, Leipzig, Germany
3 University Hospital Jena, Jena, Germany
4 Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany
5 Institut Dr. Schauerte GmbH, Munich, Germany

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing